Objective: This study aimed to determine the prevalence of serological markers for hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and occult HBV infection among injection drug users (IDUs) with isolated anti-hepatitis B core (anti-HBc).
Methods: A total of 153 male IDUs were tested for anti-hepatitis B surface (anti-HBs), hepatitis B surface antigen (HBsAg), anti-HBc, anti-HCV, and anti-HIV. The presence of HBV-DNA was determined in plasma samples of individuals with isolated anti-HBc (HBsAg negative, anti-HBs negative, and anti-HBc positive) by polymerase chain reaction (PCR).
Results: The prevalence of markers for viral hepatitis and HIV infections was 59.5% for anti-HCV, 44.4% for anti-HBs, 22.9% for anti-HBc, 7.2% for HBsAg, and 5.9% for anti-HIV. Several markers for coinfection, including HBV-HCV (5.9%), HCV-HIV (5.2%), HBV-HIV (2.0%), and HBV-HCV-HIV (1.3%), were present. Of the 7.2% of IDUs with isolated anti-HBc, all were anti-HCV positive and 18.2% were anti-HIV positive; however, no cases had detectable HBV-DNA as a marker of occult infection.
Conclusions: Markers for HCV, HBV, HIV, and combinations of these infections were common among IDUs in a city of central Iran. Isolated anti-HBc was associated with HCV but not with occult HBV infection in this sample. The 10-fold higher prevalence of HCV than HIV infection may be a harbinger of increasing HIV among IDUs in this area.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/ADM.0b013e3182659928 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Safety of Hepatitis B Virus Screening in Blood Donors from the Hospital Foundation of Hematology and Hemotherapy of the State of Amazonas (HEMOAM) in the Brazilian Amazon.
Viruses
October 2024
Programa de Pós-Graduação em Hematologia e Hemoterapia do Amazonas (PPGH/UEA/HEMOAM), Manaus 69050-001, Amazonas, Brazil.
Background: Hepatitis B is an infectious disease of worldwide importance and of great interest to transfusion medicine. The Amazon region has areas of high endemicity, outlining a worrying scenario for transfusion and epidemiological safety.
Objective: To analyze the profiles of serological and molecular markers for HBV of blood donors from HEMOAM.
Incidence of Occult Hepatitis B Infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon.
PLoS One
October 2024
Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Article Synopsis
- * A study of 288 HBsAg-negative blood donors revealed that 4.5% had OBI, with prevalent HBV genotypes A and E, highlighting the need for better detection methods.
- * Key mutations were found in OBI cases, suggesting that current testing methods may overlook infections, therefore emphasizing the need for nucleic acid testing (NAT) to improve blood safety.
International review of blood donation screening for anti-HBc and occult hepatitis B virus infection.
Transfusion
November 2024
NHS Blood and Transplant, UK.
Article Synopsis
- Hepatitis B core antibody (anti-HBc) screening is used in blood establishments worldwide to help prevent the transmission of hepatitis B virus (HBV), especially from donors with occult HBV infection (OBI).
- A survey conducted revealed varied practices in HBV screening across 30 responses from 25 countries, with some establishments screening all donations for anti-HBc and HBV DNA, while others had different approaches, leading to inconsistencies in donor deferral strategies.
- The findings highlight the need for improved confirmation of anti-HBc results to minimize unnecessary donor deferrals while balancing the risk of transmission from anti-HBc negative OBI donors, particularly in high-endemic regions where sensitive HBV DNA testing is crucial.
Self-reported exposure to blood and body fluids and serological evidence of lifetime exposure to hepatitis B virus among health care workers in Ghana: a cross-sectional study.
BMC Infect Dis
September 2024
Department of Nursing, University of Health and Allied Sciences, Ho, Volta Region, Ghana.
Introduction: In Sub-Saharan Africa alone, about 40-65% of Hepatitis B Virus infections among HCWs were a result of percutaneous occupational exposures to contaminated blood and body fluids of patients. Occupational exposure to blood and body fluids among healthcare workers is on the rise in Ghana. However, the relationship between self-reported exposures to blood and body fluids suspected to be contaminated with the hepatitis B virus and actual serological evidence of exposure remains unknown.
View Article and Find Full Text PDFHepatitis B virus infection and vaccination among people who use drugs in Xi'an, China.
Vaccine
October 2024
Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China; Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi'an, Shaanxi, China. Electronic address:
Background: While hepatitis B virus (HBV) infection in children has declined dramatically in China due to the vaccination strategy for newborns, HBV infection in high-risk adults is receiving an increasing attention. The number of people who use drugs (PWUD) in China is huge, but their status of HBV infection and vaccination is less reported, especially from large samples. The related knowledge can help decision makers develop the further strategy of HBV prevention and control.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!